Journals / Haydarpaşa Numune Medical Journal / 2020 / Cilt: 60 - Sayı: 1

Do Thyroid Hormones have any Effects on the Development of Retinopathy of Prematurity?

Pages
60–66
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Larger and prospective studies may shed light on the effects of thyroid hormones on ROP development.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Retinopathy of prematurity (ROP) is a disease characterized by abnormal vascularization of the retina in preterm infants.
📊
Key Findings & Data:Methods: This retrospective study included infants born <34 weeks of gestation between January 2011 and January 2019 who were hospitalized from birth to at least the first month of life in the Neonatal Intensive Care Unit and who had regular ROP examinations.
💡
Conclusion & Impact:Larger and prospective studies may shed light on the effects of thyroid hormones on ROP development.
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Özet

Introduction: Retinopathy of prematurity (ROP) is a disease characterized by abnormal vascularization of the retina in preterm infants. The present study aims to investigate the relationship between ROP and serum thyroid hormones based on the known effects of thyroid hormones on angiogenesis. Methods: This retrospective study included infants born <34 weeks of gestation between January 2011 and January 2019 who were hospitalized from birth to at least the first month of life in the Neonatal Intensive Care Unit and who had regular ROP examinations. The patients were divided into two groups as having ROP and no ROP. Patients diagnosed as ROP were divided into two subgroups as follows: treated ROP and untreated ROP. Variables, such as gender, gestational age (GA), birth weight (BW), bronchopulmonary dysplasia (BPD), duration of mechanical ventilation, duration of oxygen therapy, necrotizing enterocolitis and intraventricular hemorrhage (IVH), together with serum-free T4 and TSH levels on postnatal 7th (sT4-1 and TSH-1) and 28th days (sT4-2 and TSH-2), were examined. Results: One hundred ninety-three infants without ROP (Group 1) and 152 infants with ROP (Group 2) enrolled in this study. Among 152 patients with ROP, 114 infants did not receive ROP treatment (Group 2a), and 38 infants received ROP treatment (Group 2b). In Group 2, free T4-1 and TSH-2 were significantly lower than in Group 1 (p<0.001). The sT4-1 and sT4-2 levels of Group 2b were significantly lower than those of Group 2a (p=0.042 and p=0.015, respectively). In the logistic regression analysis of risk factors, thyroid hormone levels were not found to be independently effective on the development of the ROP. Discussion and Conclusion: In this study, the findings suggest that thyroid hormones had no effect on ROP development. Larger and prospective studies may shed light on the effects of thyroid hormones on ROP development.

🔖

Cite This Article

COŞKUN, Y., KIZILOĞLU, Ö. Y., BAYRAM, T., DEMİRCİ, E., AKMAN, İ. (2020). Do Thyroid Hormones have any Effects on the Development of Retinopathy of Prematurity?. Haydarpaşa Numune Medical Journal, Cilt: 60 - Sayı: 1, 60–66. https://ajindex.com/articles/159398

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Kim SJ, Port AD, Swan R, Campbell JP, Chan RVP, Chiang MF. Retinopathy of prematurity: a review of risk factors and their clinical significance. Surv Ophthalmol 2018;63:618–37
  2. Bas AY, Koc E, Dilmen U; ROP Neonatal Study Group. Incidence and severity of retinopathy of prematurity in Turkey. Br J Ophthalmol 2015;99:1311–4
  3. ASHTON N, WARD B, SERPELL G. Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia. Br J Ophthalmol 1954;38:397–432
  4. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994;35:101–11
  5. Morreale de Escobar G, Obregon MJ, Escobar del Rey F. Role of thyroid hormone during early brain development. Eur J Endocrinol 2004;151:U25–37
  6. Fi Fisher DA, Dussault JH, Sack J, Chopra IJ. Ontogenesis of hypothalamic-pituitary-thyroid function and metabolism in man, sheep, and rat. Recent Prog Horm Res 1976;33:59–116
  7. Fisher DA, Odell WD. Acute release of thyrotropin in the newborn. J Clin Invest 1969;48:1670–7
  8. Aktas ON, Gursoy T, Soysal E, Esencan E, Ercin S. Thyroid hormone levels in late preterm, early term and term infants: a study with healthy neonates revealing reference values and factors affecting thyroid hormones. J Pediatr Endocrinol Metab 2017;30:1191–6. 9. van Wassenaer AG, Kok JH, Dekker FW, de Vijlder JJ. Thyroid function in very preterm infants: influences of gestational age and disease. Pediatr Res 1997;42:604–9
  9. Carmona-Cortés J, Rodríguez-Gómez I, Wangensteen R, Banegas I, García-Lora ÁM, Quesada A, et al. Effect of thyroid hormone-nitric oxide interaction on tumor growth, angiogenesis, and aminopeptidase activity in mice. Tumour Biol 2014;35:5519–26
  10. Liu X, Zheng N, Shi YN, Yuan J, Li L. Thyroid hormone induced angiogenesis through the integrin αvβ3/protein kinase D/ histone deacetylase 5 signaling pathway. Mol Endocrinol 2014;52:245–54
  11. Zhang L, Cooper-Kuhn CM, Nannmark U, Blomgren K, Kuhn HG. Stimulatory effects of thyroid hormone on brain angiogenesis in vivo and in vitro. J Cereb Blood Flow Metab 2010;30:323–35
  12. Fierson WM; American Academy of Pediatrics Section on Ophthalmology; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus; American Association of Certified Orthoptists. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2018;142. pii: e20183061
  13. Inter